Andere Kunden interessierten sich auch für
![Melanoma, an Issue of Hematology/Oncology Clinics of North America]( "Melanoma, an Issue of Hematology/Oncology Clinics of North America")
Melanoma, an Issue of Hematology/Oncology Clinics of North America69,99 €![Emerging Therapies Targeting the Pathophysiology of Sickle Cell Disease, an Issue of Hematology/Oncology Clinics]( "Emerging Therapies Targeting the Pathophysiology of Sickle Cell Disease, an Issue of Hematology/Oncology Clinics")
Emerging Therapies Targeting the Pathophysiology of Sickle Cell Disease, an Issue of Hematology/Oncology Clinics113,99 €![Complement-Mediated Hemolytic Anemias, an Issue of Hematology/Oncology Clinics of North America]( "Complement-Mediated Hemolytic Anemias, an Issue of Hematology/Oncology Clinics of North America")
Complement-Mediated Hemolytic Anemias, an Issue of Hematology/Oncology Clinics of North America57,99 €![Sickle Cell Syndromes, an Issue of Hematology/Oncology Clinics of North America]( "Sickle Cell Syndromes, an Issue of Hematology/Oncology Clinics of North America")
Sickle Cell Syndromes, an Issue of Hematology/Oncology Clinics of North America72,99 €![Melanoma, an Issue of Hematology/Oncology Clinics]( "Melanoma, an Issue of Hematology/Oncology Clinics")
Melanoma, an Issue of Hematology/Oncology Clinics57,99 €![New Developments in the Understanding and Treatment of Autoimmune Hemolytic Anemia, an Issue of Hematology/Oncology Clinics of North America]( "New Developments in the Understanding and Treatment of Autoimmune Hemolytic Anemia, an Issue of Hematology/Oncology Clinics of North America")
New Developments in the Understanding and Treatment of Autoimmune Hemolytic Anemia, an Issue of Hematology/Oncology Clinics of North America72,99 €![Colorectal Cancer, an Issue of Hematology/Oncology Clinics of North America]( "Colorectal Cancer, an Issue of Hematology/Oncology Clinics of North America")
Colorectal Cancer, an Issue of Hematology/Oncology Clinics of North America72,99 €
This issue of Hematology/Oncology Clinics of North America, devoted to Multiple Myeloma, is edited by Dr. Kenneth C. Anderson. Articles in this issue include: Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma; Diagnosis and Risk Stratification in Myeloma; Treatment of Newly Diagnosed Transplant Eligible Patients; Treatment of Newly Diagnosed Transplant Ineligible Patients; Treatment of Relapsed/Refractory Myeloma; Maintenance Therapy; Novel Targeted Therapies; Novel Immune-based Therapies; Allotransplantation in Myeloma; and Waldenstrom's Macroglobulinemia.